Prescription medication prices to rise

15 July 2022 - The price of nearly 900 prescription medications will rise by as much as $7 on October ...

Read more →

New Australian agency to accelerate genomic research and drive innovation in health care

21 March 2022 - Genomics advances will help develop revolutionary treatments for some of our biggest health challenges, including diagnosing ...

Read more →

Strategies for generic/biosimilar market entry in Australia

19 October 2021 - After surviving the Great Patent Cliff of 2011–2016, the pharma/biopharma industry finds itself in the Second Great ...

Read more →

Commonwealth fails in its claim for compensation for delayed PBS listing of generic clopidogrel

29 April 2020 - The decision highlights the inherent difficulty Courts face in cases involving claims on the Usual Undertaking. ...

Read more →

ACCC loses appeal against Pfizer over Lipitor sales

25 May 2018 - A court has dismissed an Australian Competition and Consumer Commission appeal in a case in which ...

Read more →

Commonwealth of Australia v Sanofi: hearing of Commonwealth's claim commences in Federal Court of Australia

31 August 2017 - A six-week hearing in the Federal Court of Australia commenced this week to decide whether the Commonwealth ...

Read more →

Budget 2017: doctors reject changes on generic drugs which could save almost $2 billion

1 May 2017 - Australians will increasingly find themselves prescribed generic drugs rather than the big-name brands, under changes to ...

Read more →

Patients will be pushed to use ‘generic drugs’ as medicine prices fall in the upcoming federal budget

21 April 2017 - Patients and taxpayers will pay less for hundreds of medicines as a result of the May ...

Read more →

$30m damages for infringement of Bayer’s Australian Yasmin patent - a “small” jurisdiction with big benefits

29 March 2017 - In a recent landmark Australian Federal Court decision, Bayer v Generic Health FCA 250, Bayer was awarded ...

Read more →

The importance of Swiss-style claims in Australia

24 February 2017 - The Federal Court has recently issued a decision that highlights the importance of including Swiss-style claims ...

Read more →

When is applying for listing on the Pharmaceutical Benefits Scheme not an infringement?

16 February 2017 - In the most recent judgement in the Australian Lyrica litigation, Nicholas J has delivered an interesting decision ...

Read more →

Generic Medicines Working Group – 1 December 2016

19 January 2017 - The communique for the Generic Medicines Working Group's 1 December meeting is now available. ...

Read more →

Generic Medicines Working Group communique

20 September 2016 - The communique from the July 2016 meeting of the Generic Medicines Working Group is now available, ...

Read more →

Schedule of Pharmaceutical Benefits - 1 August 2016 update

1 August 2016 - The August 2016 issue of the Schedule of Pharmaceutical Benefits is now available and in effect. ...

Read more →

Big pharma gaming patents for extra cash: Productivity Commission

29 April 2016 - Global pharmaceutical giants are boosting revenues by unnecessarily extending patents in Aus­tralia, which is also slowing access ...

Read more →